Waters Corp, US9418481035

Waters Corp stock gains attention as new BD FACSDiscover A7 launch underpins growth story

Published on 09/15/2026 at 13:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Waters Corp stock is backed by fresh product news after the company announced the global launch of the BD FACSDiscover A7 Cell Analyzer on September 14, 2026. The shares stand near multi-year highs, supported by years of double-digit total returns.

Fotorealistisches Labor mit Chromatographie- und Massenspektrometrie-Geräten
Waters Corporation (ISIN US9418481035) zeigt moderne Analysengeräte für Chromatographie und Massenspektrometrie im Labor, Illustration mit AI erstellt.

Waters Corporation stock (ISIN US9418481035) remains supported by strong long term performance, with an investor who put USD 1,000 into the shares 20 years ago now sitting on about USD 9,062.58 based on a recent price of USD 407.00 as of September 14, 2026, according to Benzinga.

New BD FACSDiscover A7 launch adds to growth narrative

As Yahoo Finance reported on September 14, 2026, Waters Corporation announced the global commercial launch of the BD FACSDiscover A7 Cell Analyzer, a spectral flow cytometry system that aims to set a benchmark in standardized advanced cell analysis.

According to Yahoo Finance, the BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with standardized workflows, making complex flow cytometry more accessible to researchers in academia, pharmaceutical companies and contract research organizations. For investors, the launch is a reminder that Waters is pushing deeper into life sciences and diagnostics markets where demand for high end analytical instruments can support recurring revenue from consumables and services.

Long term returns highlight strength of the business model

Over the past two decades, Waters Corporation shares have delivered an annualized return of 11.74 percent, beating the broader market by 2.59 percentage points per year based on the comparison cited by Benzinga. That performance means USD 1,000 invested 20 years earlier would have grown to about USD 9,062.58 by September 14, 2026, while a simple market index would have produced a lower outcome.

The same analysis from Benzinga underscores how compounding at 11.74 percent a year translates into more than a ninefold increase in capital over 20 years. For retail investors, that quantified gap versus the market is a concrete sign that Waters Corporation’s focus on specialized analytical technologies has historically turned into shareholder value.

Stock level and market perspective

Based on the same USD 407.00 share price cited on September 14, 2026, the implied appreciation from the initial USD 50.00 level 20 years ago (historical assumption in the comparison) is significant, with the stock roughly eight times higher in nominal terms in addition to any dividends. At USD 407.00, Waters Corporation stock is trading near the upper end of its historical range, which for many investors justifies a closer look at how new product launches such as the BD FACSDiscover A7 Cell Analyzer might support future growth.

Recent price snapshot and investor takeaway

Waters Corporation stock most recently changed hands at about USD 407.00 on the New York Stock Exchange as of September 14, 2026, representing the reference level for the long term performance comparison. At this price, the shares stand well above the levels seen a decade ago and reflect the market’s expectation that Waters can continue to grow its installed base of instruments, software and consumables in life sciences and diagnostics.

Key data on Waters Corporation stock

  • Company: Waters Corporation
  • ISIN: US9418481035
  • Ticker: WAT
  • Trading venue: New York Stock Exchange
  • Price (as of September 14, 2026): 407.00 USD
  • Sector / Industry: Life sciences tools and services
  • Index membership: S&P 500

More news and analyses on Waters Corporation stock

Disclaimer...

en | US9418481035 | WATERS CORP | boerse | 70105048 | bgmi